Risk factor
Very poor trading liquidity
Profitability factor
Very strong margins and returns
About
Biohit Oyj, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. The company's diagnostic tests product range includes the GastroPanel test for diagnosing diseases of the stomach and associated risks; Biohit Active B12, a test for measuring the levels of active vitamin B12; Biohit Total, an...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB
Target Price
The average target price of BIOBV.HE is 3.5 and suggests 46% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell